Total Credits: 1.25 including 1.25 AOA Category 1-A Credit(s)
This presentation reviews the impacts of autism on key developmental periods from infancy through mature adulthood and the interaction of neurobiology and environment in the process. Using this background, effective approaches to creating a supportive environment and effective interventions will be described and illustrated with case vignettes.
Learning Objectives:
1. Identify success and challenges and developmental progression through the life cycle for people with developmental disabilities and their families
2. Identify and effectively treat comorbidities associated with ASD
3. Identify ways to build resilience in people with developmental disorders
Accreditation:
OPSC is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. OPSC designates this program for the a maximum of one (1) hour of AOA Category 1-A credits and will report CME and speciality credits commensurate with the extent of the physician's participation in this activity.
| Hendren.pdf (2.00 MB) | Available after Purchase | ||
Robert L. Hendren, D.O., is Professor of Psychiatry and Behavioral Science; Division of Child and Adolescent Psychiatry; Co-Director of the UCSF Dyslexia Center; and Director, Program for Research On Neurodevelopmental and Translational Outcomes (PRONTO). Dr. Hendren is Past President of the American Academy of Child and Adolescent Psychiatry (2007-2009). He has published well over 100 scientific papers and 5 books and has been listed in “The Best Doctors in America”, each year since it was first published in 1996.
Dr. Hendren earned his DO degree from Kirksville College of Osteopathic Medicine; did a rotating internship at Doctor’s Columbus; took his residency in general psychiatry at the Mayo Graduate School of Medicine, and his child and adolescent psychiatry fellowship at the Yale Child Study Center. He is board certified in General as well as Child and Adolescent Psychiatry. From 2001-2009, he was Professor of Psychiatry and Executive Director and Tsakopoulos-Vismara Chair at the University of California, Davis M.I.N.D. Institute (Medical Investigation of Neurodevelopmental Disorders).
His current areas of research and publication interests are translational interventional outcomes research including clinical pharmacology, nutraceutical and nutritional trials using biomarkers (metabolomics, measures of inflammation, oxidative stress, immune function, pharmacogenomics and neuroimaging) to enhance resilience in neurodevelopmental disorders. He is currently applying a targeted outcomes research approach in collaborative projects with the Oak Hill School for youth with severe autism and neurodevelopmental spectrum disorders in San Anselmo, CA, Meristem Academy in Sacramento, and the Charles Armstrong School for youth with dyslexia in Belmont, CA.